Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724119 | SCV000224589 | uncertain significance | not provided | 2014-10-29 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000173471 | SCV000595674 | likely benign | not specified | 2017-10-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000724119 | SCV001005516 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724119 | SCV001785873 | likely benign | not provided | 2019-10-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000724119 | SCV002497740 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | MAGEL2: BS1, BS2 |
Ambry Genetics | RCV002516588 | SCV003705255 | likely benign | Inborn genetic diseases | 2022-03-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |